Alicia M. Chenoweth

1.7k total citations · 3 hit papers
21 papers, 872 citations indexed

About

Alicia M. Chenoweth is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Alicia M. Chenoweth has authored 21 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Alicia M. Chenoweth's work include Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (7 papers) and CAR-T cell therapy research (5 papers). Alicia M. Chenoweth is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (7 papers) and CAR-T cell therapy research (5 papers). Alicia M. Chenoweth collaborates with scholars based in United Kingdom, Australia and France. Alicia M. Chenoweth's co-authors include Silvia Crescioli, Janice M. Reichert, Hélène Kaplon, Jyothsna Visweswaraiah, Bruce D. Wines, P. Mark Hogarth, Sophia N. Karagiannis, Anthony Cheung, Sophia Tsoka and David E. Thurston and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and Immunological Reviews.

In The Last Decade

Alicia M. Chenoweth

19 papers receiving 834 citations

Hit Papers

Antibodies to watch in 2022 2022 2026 2023 2024 2022 2022 2024 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia M. Chenoweth United Kingdom 12 471 444 294 220 58 21 872
Huaizu Guo China 18 371 0.8× 492 1.1× 415 1.4× 257 1.2× 59 1.0× 41 988
Silvia Crescioli United Kingdom 17 625 1.3× 625 1.4× 450 1.5× 464 2.1× 89 1.5× 33 1.3k
Amita Datta‐Mannan United States 18 828 1.8× 832 1.9× 294 1.0× 244 1.1× 88 1.5× 37 1.2k
Christian Gassner Switzerland 9 442 0.9× 704 1.6× 189 0.6× 186 0.8× 43 0.7× 15 1.0k
Kay Stubenrauch Germany 16 883 1.9× 757 1.7× 446 1.5× 224 1.0× 70 1.2× 33 1.4k
Gordon Powers United States 14 275 0.6× 423 1.0× 526 1.8× 223 1.0× 25 0.4× 25 1.1k
Qingrong Yan United States 14 236 0.5× 444 1.0× 537 1.8× 366 1.7× 34 0.6× 17 1.0k
Andrew Buchanan United Kingdom 15 368 0.8× 417 0.9× 97 0.3× 138 0.6× 35 0.6× 30 688
Antje‐Christine Walz Switzerland 15 166 0.4× 402 0.9× 153 0.5× 349 1.6× 88 1.5× 34 892
Gregory L. Moore United States 18 649 1.4× 639 1.4× 432 1.5× 318 1.4× 87 1.5× 42 1.2k

Countries citing papers authored by Alicia M. Chenoweth

Since Specialization
Citations

This map shows the geographic impact of Alicia M. Chenoweth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia M. Chenoweth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia M. Chenoweth more than expected).

Fields of papers citing papers by Alicia M. Chenoweth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia M. Chenoweth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia M. Chenoweth. The network helps show where Alicia M. Chenoweth may publish in the future.

Co-authorship network of co-authors of Alicia M. Chenoweth

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia M. Chenoweth. A scholar is included among the top collaborators of Alicia M. Chenoweth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia M. Chenoweth. Alicia M. Chenoweth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crescioli, Silvia, et al.. (2026). Antibodies to watch in 2026. mAbs. 18(1). 2614669–2614669.
2.
Grandits, Melanie, Lais C. G. F. Palhares, Gabriel Osborn, et al.. (2025). Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors. Journal for ImmunoTherapy of Cancer. 13(3). e010945–e010945. 3 indexed citations
3.
Miller, Claire, et al.. (2025). Mathematical modelling of macrophage and natural killer cell immune response during early stages of peritoneal endometriosis lesion onset. Journal of The Royal Society Interface. 22(229). 20250076–20250076.
4.
Liu, Yi, et al.. (2025). Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age. mAbs. 17(1). 2470309–2470309. 2 indexed citations
5.
Chenoweth, Alicia M., et al.. (2024). In Vivo PET Imaging of89Zr-Labeled Natural Killer Cells and the Modulating Effects of a Therapeutic Antibody. Journal of Nuclear Medicine. 65(7). 1035–1042. 9 indexed citations
6.
Palhares, Lais C. G. F., Jenifer L. Hendel, Richard A. Gardner, et al.. (2024). IgE glycosylation and impact on structure and function: A systematic review. Allergy. 79(10). 2625–2661. 3 indexed citations
7.
Crescioli, Silvia, et al.. (2024). Antibodies to watch in 2024. mAbs. 16(1). 2297450–2297450. 100 indexed citations breakdown →
8.
Chenoweth, Alicia M., et al.. (2023). Drug repurposing and prediction of multiple interaction types via graph embedding. BMC Bioinformatics. 24(1). 202–202. 20 indexed citations
10.
Chenoweth, Alicia M., Sandra Esparon, Bruce D. Wines, et al.. (2023). Mutation of the TGN1412 anti‐CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super‐agonist activity. Immunology and Cell Biology. 101(7). 657–662. 4 indexed citations
11.
Cheung, Anthony, Alicia M. Chenoweth, Jelmar Quist, et al.. (2022). CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models. Cancers. 14(14). 3361–3361. 11 indexed citations
12.
Kaplon, Hélène, Alicia M. Chenoweth, Silvia Crescioli, & Janice M. Reichert. (2022). Antibodies to watch in 2022. mAbs. 14(1). 2014296–2014296. 258 indexed citations breakdown →
13.
Kaplon, Hélène, Silvia Crescioli, Alicia M. Chenoweth, Jyothsna Visweswaraiah, & Janice M. Reichert. (2022). Antibodies to watch in 2023. mAbs. 15(1). 2153410–2153410. 193 indexed citations breakdown →
14.
Gardner, Richard A., Anna M. Davies, Daniel I. R. Spencer, et al.. (2022). Generation and Characterization of Native and Sialic Acid-Deficient IgE. International Journal of Molecular Sciences. 23(21). 13455–13455. 6 indexed citations
15.
Chauhan, Jitesh, Heather J. Bax, Chara Stavraka, et al.. (2021). Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments. Cancers. 13(17). 4460–4460. 24 indexed citations
16.
Chenoweth, Alicia M., et al.. (2021). Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer. British Journal of Cancer. 125(5). 748–758. 21 indexed citations
17.
Chenoweth, Alicia M., et al.. (2020). Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs. Immunology and Cell Biology. 98(4). 287–304. 42 indexed citations
18.
Chenoweth, Alicia M., et al.. (2019). The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease. Frontiers in Immunology. 10. 464–464. 94 indexed citations
19.
Trist, Halina M., Catherine S. Palmer, Peck Szee Tan, et al.. (2018). The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1. Frontiers in Immunology. 9. 1809–1809. 7 indexed citations
20.
Chenoweth, Alicia M., et al.. (2015). The high‐affinity receptor for IgG, FcγRI, of humans and non‐human primates. Immunological Reviews. 268(1). 175–191. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026